Clinical Trial Update: A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 trial of a recombinant Factor IX in patients with severe Hemophilia B; the study completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Recombinant Factor IX (Factor IX)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-09